Inovio updates governance, passes all 2026 meeting votes
Inovio Pharmaceuticals, Inc. reported governance changes and voting results from its 2026 annual stockholder meeting.
Rhea-AI Filing Summary
Inovio Pharmaceuticals, Inc. reported governance changes and voting results from its 2026 annual stockholder meeting. On May 19, 2026, the board approved a bylaws amendment clarifying that the Chairman of the Board is not an officer unless specifically designated, formally creating a Lead Independent Director role when the Chief Executive Officer also serves as Chairman, and updating the order of presiding officers at board and stockholder meetings.
On May 20, 2026, stockholders holding 40,670,629 shares, or 58.57% of the 69,438,100 shares entitled to vote, were present or represented by proxy. All eight director nominees were elected. Stockholders ratified Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2026, approved on a non-binding basis the compensation of named executive officers, and approved amendments to the Amended and Restated 2023 Omnibus Incentive Plan.
Positive
- None.
Negative
- None.
8-K Event Classification
3 items: 5.03, 5.07, 9.01
3 items
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Shares entitled to vote: 69,438,100 shares
Shares present or by proxy: 40,670,629 shares
Quorum percentage: 58.57%
+3 more
6 metrics
Shares entitled to vote
69,438,100 shares
Common stock entitled to vote as of record date for 2026 Annual Meeting
Shares present or by proxy
40,670,629 shares
Shares represented at 2026 Annual Meeting, 58.57% of entitled shares
Quorum percentage
58.57%
Portion of entitled common stock represented at 2026 Annual Meeting
Auditor ratification - For votes
39,329,582 votes
Votes in favor of ratifying Ernst & Young LLP for fiscal year ending December 31, 2026
Say-on-pay - For votes
21,500,999 votes
Votes approving NEO compensation on non-binding basis at 2026 Annual Meeting
Incentive plan amendment - For votes
21,559,350 votes
Votes approving amendment and restatement of 2023 Omnibus Incentive Plan
Key Terms
Lead Independent Director, broker non-votes, non-binding advisory basis, independent registered public accounting firm, +1 more
5 terms
Lead Independent Director financial
"establishing the position of Lead Independent Director, including the designation, duties and responsibilities thereof"
A lead independent director is a board member who is not part of company management and is chosen to coordinate and represent the other independent directors, often running sessions without the CEO, helping set meeting agendas, and serving as a liaison between shareholders and the board. For investors, this role signals stronger, more balanced oversight—like a neutral referee who helps ensure decisions are fair, transparent and focused on protecting shareholder interests.
broker non-votes financial
"The votes were cast as follows ... Broker Non-Votes 17,091,251"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
non-binding advisory basis financial
"The approval, on a non-binding advisory basis, of the compensation of the NEOs described in the Proxy Statement."
A non-binding advisory basis is guidance or a recommendation offered for informational purposes that does not create legal obligations or guarantees; recipients can accept, modify, or ignore it without contractual consequences. Investors should treat it like a weather forecast for planning—useful for forming expectations and assessing risk, but not a firm promise—so they should verify assumptions, seek confirming information, and avoid relying on it as the sole basis for investment decisions.
independent registered public accounting firm financial
"Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026."
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Omnibus Incentive Plan financial
"The approval of the amendment and restatement of the Company’s Amended and Restated 2023 Omnibus Incentive Plan"
An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.
FAQ
What governance changes did Inovio (INO) make to its bylaws in May 2026?
Inovio’s board approved a bylaws amendment clarifying board leadership roles. It defined the Chairman’s status as a non-officer unless designated, established a Lead Independent Director role with specific duties, and updated the order of presiding officers at board and stockholder meetings to reflect these leadership changes.
Were all Inovio (INO) director nominees elected at the 2026 annual meeting?
Yes, all eight director nominees were elected. Each nominee, including Simon X. Benito, Roger D. Dansey, Ann C. Miller, Jacqueline E. Shea, Jay P. Shepard, David B. Weiner, Wendy L. Yarno, and Lota S. Zoth, received more votes “For” than “Withheld,” with substantial broker non-votes recorded.
Did Inovio (INO) stockholders ratify Ernst & Young as the 2026 auditor?
Yes, Ernst & Young LLP was ratified as auditor for 2026. The ratification received 39,329,582 votes “For,” 1,198,040 “Against,” and 143,007 “Abstain,” with no broker non-votes, confirming stockholder support for the company’s chosen independent registered public accounting firm.
How did Inovio (INO) investors vote on executive compensation in 2026?
Stockholders approved executive compensation on a non-binding basis. The say-on-pay proposal received 21,500,999 votes “For,” 1,607,592 “Against,” 470,787 “Abstain,” and 17,091,251 broker non-votes, indicating majority support for the named executive officers’ compensation described in the proxy statement.
What happened with Inovio’s 2023 Omnibus Incentive Plan at the 2026 meeting?
Stockholders approved amendments to the 2023 Omnibus Incentive Plan. The proposal to amend and restate the plan received 21,559,350 votes “For,” 1,535,940 “Against,” 484,088 “Abstain,” and 17,091,251 broker non-votes, allowing the company to continue using the updated equity incentive framework.
AI-generated analysis. How Rhea-AI works. Not financial advice.
